Tinnitus Retraining Therapy Trial (TRTT)
Sponsor: 59th Medical Wing
This PHASE3 trial investigates Subjective Tinnitus and is currently completed. 59th Medical Wing leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
May 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Dec 2018 — May 2020 [monthly]
Completed PHASE3
▶ Show 3 earlier versions
-
Jun 2018 — Dec 2018 [monthly]
Completed PHASE3
-
Mar 2017 — Jun 2018 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jan 2017 — Mar 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- 59th Medical Wing
- David Grant U.S. Air Force Medical Center
- Johns Hopkins Bloomberg School of Public Health
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- Naval Hospital Camp Pendleton
- United States Naval Medical Center, Portsmouth
- United States Naval Medical Center, San Diego
- University of Alabama, Tuscaloosa
- Walter Reed National Military Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .